These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 209796)

  • 21. Plasma lipoprotein composition in cholesterol fed rabbits treated with pirinixil (BR 931), a new lipid lowering agent.
    Lovati MR; De Marchi G
    Pharmacol Res Commun; 1981 Feb; 13(2):133-9. PubMed ID: 7220573
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
    Weisweiler P; Schwandt P
    Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypolipidemic activity of 6-amino-2-mercapto-5-methyl-pyrimidine-4-carboxylic acid and related derivatives in rodents.
    Hall IH; Cocolas GH; Murthy AR; Rhyne KA; Knowles M
    J Pharm Sci; 1985 Jul; 74(7):759-64. PubMed ID: 4032250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of type III hyperlipoproteinemia with four different treatment regimens.
    Hoogwerf BJ; Bantle JP; Kuba K; Frantz ID; Hunninghake DB
    Atherosclerosis; 1984; 51(2-3):251-9. PubMed ID: 6588975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newer hypolipidemic compounds.
    Kritchevsky D
    Adv Exp Med Biol; 1975; 63():135-50. PubMed ID: 1106139
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of trapidil on experimental hyperlipemia and atherosclerosis induced by cholesterol diet in SPF Japanese white rabbits].
    Gotoh H; Tonooka M; Nakayama S; Sakamoto K
    Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):303-19. PubMed ID: 6231231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hypolipidemic effect of artesunate and ursolic acid in rats.
    Yuliang W; Zejian W; Hanlin S; Ming Y; Kexuan T
    Pak J Pharm Sci; 2015 May; 28(3):871-4. PubMed ID: 26004719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of BM 15.075 on lipoprotein concentrations in different types of hyperlipoproteinaemia.
    Olsson AG; Rössner S; Walldius G; Carlson LA; Lang PD
    Atherosclerosis; 1977 Jul; 27(3):279-87. PubMed ID: 901625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of NIP-200 on hyperlipidemia and atherosclerosis in cholesterol-fed rabbits].
    Sakamoto K; Yamauchi M; Nakayama S; Tsuruzoe N; Sakashita M; Fujikawa Y
    Nihon Yakurigaku Zasshi; 1987 Oct; 90(4):187-93. PubMed ID: 3428776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HVC1 ameliorates hyperlipidemia and inflammation in LDLR
    Cheon SY; Chung KS; Lee KJ; Choi HY; Ham IH; Jung DH; Cha YY; An HJ
    BMC Complement Altern Med; 2017 Apr; 17(1):222. PubMed ID: 28427397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental studies on the hypolipidemic activity of chloridarol.
    Bernini F; Musanti R; Trezzi E; Corsini A; Fumagalli R; Meldolesi J; Catapano AL
    Pharmacol Res Commun; 1983 Feb; 15(2):201-15. PubMed ID: 6844377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic peroxisome proliferation: induction by BR-931, a hypolipidemic analog of WY-14,643.
    Reddy JK; Azarnoff DL; Sirtori CR
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):4-14. PubMed ID: 708142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of clofibrate on lipid metabolism in streptozotocin diabetic rats.
    Cayen MN; Dubuc J; Dvornik D
    Proc Soc Exp Biol Med; 1975 Mar; 148(3):752-7. PubMed ID: 165533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes, postprandial lipoprotein metabolism, and lipoprotein distribution and composition.
    Föger B; Tröbinger G; Ritsch A; Lechleitner M; Hopferwieser T; Menzel HJ; Utermann G; Pfeiffer KP; Patsch JR
    Atherosclerosis; 1995 Oct; 117(2):253-61. PubMed ID: 8801871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow-fed animals.
    O'Brien M; Patel ST; Mukhopadhyay A; Newman HA; Feller DR; Kokrady SS; Witiak DT; Lanese RR; Rice JC
    Lipids; 1981 Dec; 16(12):903-11. PubMed ID: 7329211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice.
    Tomikawa M; Nakayasu T; Tawara K; Abiko Y
    Atherosclerosis; 1981 Oct; 40(2):101-13. PubMed ID: 6946776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of pancreatic lipase, α-glucosidase, α-amylase, and hypolipidemic effects of the total flavonoids from Nelumbo nucifera leaves.
    Liu S; Li D; Huang B; Chen Y; Lu X; Wang Y
    J Ethnopharmacol; 2013 Aug; 149(1):263-9. PubMed ID: 23811214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
    Olsson AG; Lang PD
    Atherosclerosis; 1978 Dec; 31(4):429-33. PubMed ID: 215175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypolipidemic effect of fenugreek seeds and its comparison with atorvastatin on experimentally induced hyperlipidemia.
    Sharma MS; Choudhary PR
    J Coll Physicians Surg Pak; 2014 Aug; 24(8):539-42. PubMed ID: 25149829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of F2833 on cholesterol metabolism in the genetically hyperlipidemic rat.
    Ouguerram K; Lutton C; Delhon A; Magot T
    Eur J Pharmacol; 2001 Mar; 415(2-3):293-9. PubMed ID: 11275012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.